{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:08:11Z","timestamp":1789549691549,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007797","name":"Helsingin Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007753","name":"It\u00e4-Suomen Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.sleep.2025.106505","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T15:40:54Z","timestamp":1744299654000},"page":"106505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Detection of reduced orexin-A\/hypocretin-1 and its fragments by orexin-A \u201cgold-standard\u201d radioimmunoassay"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6989-1564","authenticated-orcid":false,"given":"Jyrki P.","family":"Kukkonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauli M.","family":"Turunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiju K.","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.sleep.2025.106505_bib1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.sleep.2025.106505_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.sleep.2025.106505_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/pharmrev.123.000953","article-title":"International union of basic and clinical pharmacology CXIV: orexin receptor function, nomenclature and pharmacology","volume":"76","author":"Kukkonen","year":"2024","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.sleep.2025.106505_bib4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.sleep.2025.106505_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.sleep.2025.106505_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(01)00293-8","article-title":"Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity","volume":"30","author":"Hara","year":"2001","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.sleep.2025.106505_bib7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0896-6273(03)00330-1","article-title":"Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes","volume":"38","author":"Willie","year":"2003","journal-title":"Neuron"},{"issue":"19","key":"10.1016\/j.sleep.2025.106505_bib8","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1523\/JNEUROSCI.0073-14.2014","article-title":"Conditional ablation of orexin\/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function","volume":"34","author":"Tabuchi","year":"2014","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.sleep.2025.106505_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/bbrc.1999.0362","article-title":"Widespread distribution of orexin in rat brain and its regulation upon fasting","volume":"256","author":"Mondal","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"issue":"9197","key":"10.1016\/j.sleep.2025.106505_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.sleep.2025.106505_bib11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.sleep.2025.106505_bib12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1750-3639.2003.tb00033.x","article-title":"Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy","volume":"13","author":"Thannickal","year":"2003","journal-title":"Brain Pathol"},{"issue":"8","key":"10.1016\/j.sleep.2025.106505_bib13","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1212\/01.wnl.0000175219.01544.c8","article-title":"Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy","volume":"65","author":"Blouin","year":"2005","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.sleep.2025.106505_bib14","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/sleep\/32.8.993","article-title":"Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy","volume":"32","author":"Thannickal","year":"2009","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.sleep.2025.106505_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ana.26300","article-title":"Reduced numbers of corticotropin-releasing hormone neurons in narcolepsy type 1","volume":"91","author":"Shan","year":"2022","journal-title":"Ann Neurol"},{"issue":"19","key":"10.1016\/j.sleep.2025.106505_bib16","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2220911120","article-title":"Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy","volume":"120","author":"Seifinejad","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.sleep.2025.106505_bib17","series-title":"Diagnostic and statistical manual of mental disorders : dsm-5","year":"2013"},{"key":"10.1016\/j.sleep.2025.106505_bib18","series-title":"International classification of sleep disorders","year":"2014"},{"key":"10.1016\/j.sleep.2025.106505_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2021.100101","article-title":"What do I talk about when I talk about measuring CNS orexin-A? Considerations of orexin-A measurements in clinical and preclinical setting","volume":"11","author":"Kukkonen","year":"2021","journal-title":"Med Drug Discov"},{"key":"10.1016\/j.sleep.2025.106505_bib20","series-title":"Contemporary clinical neuroscience: the orexin\/hypocretin system: physiology and pathophysiology","first-page":"73","article-title":"Hypocretin measurements in the CSF, and blood and brain tissue. Basic and clinical applications","author":"Nishino","year":"2005"},{"key":"10.1016\/j.sleep.2025.106505_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/srep25162","article-title":"From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid","volume":"6","author":"Hirtz","year":"2016","journal-title":"Sci Rep"},{"issue":"14","key":"10.1016\/j.sleep.2025.106505_bib22","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1021\/acs.analchem.9b02710","article-title":"Considerably lower levels of hypocretin-1 in cerebrospinal fluid is revealed by a novel mass spectrometry method compared with standard radioimmunoassay","volume":"91","author":"B\u00e5rdsen","year":"2019","journal-title":"Anal Chem"},{"key":"10.1016\/j.sleep.2025.106505_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.clinbiochem.2021.01.009","article-title":"Orexin-A measurement in narcolepsy: a stability study and a comparison of LC-MS\/MS and immunoassays","volume":"90","author":"Lindstr\u00f6m","year":"2021","journal-title":"Clin Biochem"},{"issue":"16","key":"10.1016\/j.sleep.2025.106505_bib24","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.3390\/molecules26165036","article-title":"LC-MS\/MS analysis elucidates a daily rhythm in orexin A concentration in the rat vitreous body","volume":"26","author":"Chrobok","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.sleep.2025.106505_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2021.100102","article-title":"Development of a LC-ESI-MRM method for the absolute quantification of orexin A in the CSF of individual mice","volume":"11","author":"Hopkins","year":"2021","journal-title":"Med Drug Discovery"},{"issue":"19","key":"10.1016\/j.sleep.2025.106505_bib26","doi-asserted-by":"crossref","first-page":"9802","DOI":"10.1021\/acs.analchem.5b02086","article-title":"Reducing adsorption to improve recovery and in vivo detection of neuropeptides by microdialysis with LC-MS","volume":"87","author":"Zhou","year":"2015","journal-title":"Anal Chem"},{"issue":"4","key":"10.1016\/j.sleep.2025.106505_bib27","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1021\/acschemneuro.2c00370","article-title":"Diurnal fluctuations of orexin-A and -B in cynomolgus Monkey cerebrospinal fluid determined by a novel analytical method using antiadsorptive additive treatment followed by nanoflow liquid chromatography-high-resolution mass spectrometry","volume":"14","author":"Narita","year":"2023","journal-title":"ACS Chem Neurosci"},{"issue":"8","key":"10.1016\/j.sleep.2025.106505_bib28","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1073\/pnas.1522691113","article-title":"Antigen clasping by two antigen-binding sites of an exceptionally specific antibody for histone methylation","volume":"113","author":"Hattori","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.sleep.2025.106505_bib29","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1080\/19420862.2017.1367074","article-title":"IgG cooperativity - is there allostery? Implications for antibody functions and therapeutic antibody development","volume":"9","author":"Yang","year":"2017","journal-title":"mAbs"},{"issue":"2","key":"10.1016\/j.sleep.2025.106505_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab050","article-title":"Pre-treatment of blood samples reveal normal blood hypocretin\/orexin signal in narcolepsy type 1","volume":"3","author":"\u00c6gidius","year":"2021","journal-title":"Brain Commun"},{"issue":"1","key":"10.1016\/j.sleep.2025.106505_bib31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41598-018-36942-8","article-title":"HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy","volume":"9","author":"Sakai","year":"2019","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.sleep.2025.106505_bib32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/pcn.12780","article-title":"Measurement of cerebrospinal fluid orexin-A (hypocretin-1) by enzyme-linked immunosorbent assay: a comparison with radioimmunoassay","volume":"72","author":"Ono","year":"2018","journal-title":"Psychiatr Clin Neurosci"},{"issue":"1","key":"10.1016\/j.sleep.2025.106505_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0022-510X(68)90006-3","article-title":"Proteinases in human cerebrospinal fluid","volume":"7","author":"Riekkinen","year":"1968","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/j.sleep.2025.106505_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010980","article-title":"Establishing the proteome of normal human cerebrospinal fluid","volume":"5","author":"Schutzer","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.sleep.2025.106505_bib35","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1074\/mcp.M114.038554","article-title":"In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR)","volume":"13","author":"Guldbrandsen","year":"2014","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"10.1016\/j.sleep.2025.106505_bib36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1021\/pr070501k","article-title":"Integrated analysis of the cerebrospinal fluid peptidome and proteome","volume":"7","author":"Zougman","year":"2008","journal-title":"J Proteome Res"},{"issue":"26","key":"10.1016\/j.sleep.2025.106505_bib37","doi-asserted-by":"crossref","first-page":"15984","DOI":"10.1016\/S0021-9258(18)55494-6","article-title":"Protein disulfide-isomerase in rat exocrine pancreatic cells is exported from the endoplasmic reticulum despite possessing the retention signal","volume":"265","author":"Yoshimori","year":"1990","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.sleep.2025.106505_bib38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.freeradbiomed.2010.11.029","article-title":"Cysteine\/cystine redox signaling in cardiovascular disease","volume":"50","author":"Go","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.sleep.2025.106505_bib39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fchem.2014.00070","article-title":"Protein disulfide isomerase a multifunctional protein with multiple physiological roles","volume":"2","author":"Ali Khan","year":"2014","journal-title":"Front Chem"},{"issue":"2\u20133","key":"10.1016\/j.sleep.2025.106505_bib40","first-page":"159","article-title":"Assay of antioxidant capacity of human plasma and CSF in aging and disease","volume":"12","author":"Alho","year":"1998","journal-title":"Restor Neurol Neurosci"},{"issue":"1","key":"10.1016\/j.sleep.2025.106505_bib41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.nbd.2003.10.003","article-title":"Plasma and CSF markers of oxidative stress are increased in Parkinson\u2019s disease and influenced by antiparkinsonian medication","volume":"15","author":"Buhmann","year":"2004","journal-title":"Neurobiol Dis"},{"issue":"17","key":"10.1016\/j.sleep.2025.106505_bib42","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1089\/ars.2017.7433","article-title":"Can oxidation-reduction potential of cerebrospinal fluid Be a monitoring biomarker in amyotrophic lateral sclerosis?","volume":"28","author":"Opacic","year":"2018","journal-title":"Antioxidants Redox Signal"},{"issue":"6","key":"10.1016\/j.sleep.2025.106505_bib43","doi-asserted-by":"crossref","first-page":"R1450","DOI":"10.1152\/ajpregu.00215.2004","article-title":"Spinal CSF absorption in healthy individuals","volume":"287","author":"Edsbagge","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"10.1016\/j.sleep.2025.106505_bib44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/jor.23448","article-title":"Cerebrospinal fluid dynamics at the lumbosacral level in patients with spinal stenosis: a pilot study","volume":"35","author":"Chun","year":"2017","journal-title":"J Orthop Res"},{"issue":"8","key":"10.1016\/j.sleep.2025.106505_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa044","article-title":"To split or to lump? Classifying the central disorders of hypersomnolence","volume":"43","author":"Fronczek","year":"2020","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.sleep.2025.106505_bib46","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsab285","article-title":"Narcolepsy with intermediate cerebrospinal level of hypocretin-1","volume":"45","author":"Postiglione","year":"2022","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.sleep.2025.106505_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsac052","article-title":"Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1","volume":"45","author":"van der Hoeven","year":"2022","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2025.106505_bib48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.sleep.2021.07.007","article-title":"Cerebrospinal fluid orexin in Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"85","author":"Treu","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2025.106505_bib49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.sleep.2022.10.016","article-title":"Functional roles of orexin in obstructive sleep apnea: from clinical observation to mechanistic insights","volume":"101","author":"Sithirungson","year":"2023","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2025.106505_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2024.108320","article-title":"Exploring the role of Orexin-A neuropeptide in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"242","author":"Suresh","year":"2024","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725001728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725001728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T11:20:29Z","timestamp":1748344829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945725001728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":50,"alternative-id":["S1389945725001728"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2025.106505","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of reduced orexin-A\/hypocretin-1 and its fragments by orexin-A \u201cgold-standard\u201d radioimmunoassay","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2025.106505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106505"}}